1. Serum osteoprotegrin (OPG) in subclinical atherosclerosis in systemic lupus erythematosus. (July 2017) Authors: Kiani, A N; Aukrust, P; Ueland, T; Hollan, I; Barr, E; Magder, L S; Petri, M Journal: Lupus Issue: Volume 26:Number 8(2017) Page Start: 865 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A polymorphism upstream MIR1279 gene is associated with pericarditis development in Systemic Lupus Erythematosus and contributes to definition of a genetic risk profile for this complication. (July 2017) Authors: Ciccacci, C; Perricone, C; Politi, C; Rufini, S; Ceccarelli, F; Cipriano, E; Alessandri, C; Latini, A; Valesini, G; Novelli, G; Conti, F; Borgiani, P Journal: Lupus Issue: Volume 26:Number 8(2017) Page Start: 841 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Retrospective review of lupus nephritis in a New Zealand multi-ethnic cohort. (July 2017) Authors: Ly, E; Thein, H; Lam Po Tang, Michael Journal: Lupus Issue: Volume 26:Number 8(2017) Page Start: 893 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study. (July 2017) Authors: Burge, D J; Eisenman, J; Byrnes-Blake, K; Smolak, P; Lau, K; Cohen, S B; Kivitz, A J; Levin, R; Martin, R W; Sherrer, Y; Posada, J A Journal: Lupus Issue: Volume 26:Number 8(2017) Page Start: 825 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Review by Hui-Yuen et al. Targeted B-cell therapies in the treatment of adult and paediatric systemic lupus erythematosus. (July 2017) Authors: Isenberg, D A Journal: Lupus Issue: Volume 26:Number 8(2017) Page Start: 900 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Belimumab for the treatment of recalcitrant cutaneous lupus. (July 2017) Authors: Vashisht, P; Borghoff, K; O'Dell, J R; Hearth-Holmes, M Journal: Lupus Issue: Volume 26:Number 8(2017) Page Start: 857 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Outcome in biopsy-proven Lupus nephritis: Evaluation of biopsies from the Norwegian Kidney Biopsy Registry. (July 2017) Authors: Norby, G E; Mjøen, G; Bjørneklett, R; Vikse, B E; Holdaas, H; Svarstad, E; Aasarød, K Journal: Lupus Issue: Volume 26:Number 8(2017) Page Start: 881 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Congenital heart block and immune mediated sensorineural hearing loss: possible cross reactivity of immune response. (July 2017) Authors: Bason, C; Pagnini, I; Brucato, A; Maestroni, S; Puccetti, A; Lunardi, C; Cimaz, R Journal: Lupus Issue: Volume 26:Number 8(2017) Page Start: 835 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Trigger factors of cutaneous lupus erythematosus: a review of current literature. (July 2017) Authors: Szczęch, J; Samotij, D; Werth, V P; Reich, A Journal: Lupus Issue: Volume 26:Number 8(2017) Page Start: 791 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Drug-induced lupus erythematosus mimicking lymphoma on 18F-FDG-PET/CT. (July 2017) Authors: Guischer, N; Houssiau, F A; Lhommel, R; Coche, E; Roelants, V Journal: Lupus Issue: Volume 26:Number 8(2017) Page Start: 898 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗